Filing Details

Accession Number:
0001104659-20-078440
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-30 08:19:11
Reporting Period:
2020-06-29
Accepted Time:
2020-06-30 08:19:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1579428 Axsome Therapeutics Inc. AXSM Pharmaceutical Preparations (2834) 454241907
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1742143 Nick Pizzie C/O Axsome Therapeutics, Inc.
200 Broadway, 3Rd Floor
New York NY 10038
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-29 777 $76.64 41,217 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 60 Indirect By UTMA account
Footnotes
  1. 777 shares were purchased by the Reporting Person's IRA.
  2. Represents 60 shares of common stock indirectly held by the reporting person as custodian for his son's UTMA account. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.